Drug information for MAKENA
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
SOLUTION; INTRAMUSCULAR
1250MG/5ML (250MG/ML)
Prescription
(Reference Drug)
HYDROXYPROGESTERONE CAPROATE
17-alpha-hydroxy-progesterone caproate
KV PHARM
21945
2011-02-10 Letter
2011-02-03 Label
Drug Adverse Effects information for MAKENA
Role code
Indications
Reaction
# Reports
PS
MATERNAL EXPOSURE DURING PREGNANCY
CAESAREAN SECTION
1
PS
MATERNAL EXPOSURE DURING PREGNANCY
CARDIAC DISORDER
1
PS
MATERNAL EXPOSURE DURING PREGNANCY
FOETAL GROWTH RESTRICTION
1
PS
MATERNAL EXPOSURE DURING PREGNANCY
HYPOGLYCAEMIA NEONATAL
1
PS
MATERNAL EXPOSURE DURING PREGNANCY
MATERNAL DRUGS AFFECTING FOETUS
3
PS
MATERNAL EXPOSURE DURING PREGNANCY
MECONIUM STAIN
1
PS
MATERNAL EXPOSURE DURING PREGNANCY
PREMATURE BABY
2
PS
PREMATURE DELIVERY
BREECH PRESENTATION
1
PS
PREMATURE DELIVERY
CAESAREAN SECTION
2
PS
PREMATURE DELIVERY
CERVIX ENLARGEMENT
1
PS
PREMATURE DELIVERY
CHORIOAMNIONITIS
1
PS
PREMATURE DELIVERY
DRUG INEFFECTIVE
1
PS
PREMATURE DELIVERY
FATIGUE
1
PS
PREMATURE DELIVERY
HEADACHE
1
PS
PREMATURE DELIVERY
INJECTION SITE DISCOMFORT
1
PS
PREMATURE DELIVERY
MATERNAL DRUGS AFFECTING FOETUS
1
PS
PREMATURE DELIVERY
MATERNAL EXPOSURE DURING PREGNANCY
5
PS
PREMATURE DELIVERY
NAUSEA
1
PS
PREMATURE DELIVERY
OFF LABEL USE
1
PS
PREMATURE DELIVERY
PREMATURE DELIVERY
1
PS
PREMATURE DELIVERY
PREMATURE LABOUR
2
PS
PREMATURE DELIVERY
PREMATURE RUPTURE OF MEMBRANES
2
PS
PREMATURE DELIVERY
PYREXIA
1
PS
PREMATURE DELIVERY
SHORTENED CERVIX
2
PS
PREMATURE DELIVERY
STILLBIRTH
1
PS
PREMATURE DELIVERY
TWIN PREGNANCY
1
PS
PREMATURE DELIVERY
UTERINE CONTRACTIONS DURING PREGNANCY
1
PS
PREMATURE DELIVERY
VULVOVAGINAL DISCOMFORT
1
PS
PREMATURE LABOUR
FLUID RETENTION
2
PS
PREMATURE LABOUR
PRURITUS
2
Ads by Google